openPR Logo
Press release

Clopidogrel Market Competitive Analysis by 2025 : Pfizer, Dr Reddy’s, Apotex Corp, Roxane Laboratories, Aurobindo Pharma

04-05-2019 12:55 PM CET | Health & Medicine

Press release from: TMR Research

Clopidogrel Market Competitive Analysis by 2025 : Pfizer, Dr

Global Clopidogrel Market: Snapshot

Clopidogrel is an antiplatelet agent of thienopyridine, which is primarily used to prevent the blood clots and help against cardiovascular problems associated with the blood clotting. The medications for inhibiting blood clots after a recent heart stroke also use clopidogrel, which is a white colored powder that is insoluble in water at neutral pH but freely soluble at pH1. Clopidogrel was the second most successful drug trailing behind Pfizer’s Lipito in 2010. Sold under the brand name Plavix, and marketed by Sanofi and Bristol-Myers Squibb, the demand for clopidogrel is escalating due to the increasing number of heart attack cases across the globe.

The patent of clopidogrel manufacturing got expires on Market 31, 2012 and is expected to prompt pharmaceutical companies to venture into clopidogrel drug manufacturing. Moreover, companies such as Dr. Reddy’s have acquired the approval to manufacture clopidogrel 300mg. Furthermore, several other organizations such as Roxane Laboratories, Aurobindo Pharma, Sun Pharma, Torrent Pharmaceuticals, and Apotex Crop have gained approval for marketing clopidogrel 75mg. Clopidogrel is also used with aspirin to treat worsening chest pain and to keep blood vessels open and present blood clots after certain heart related operations.

Request Sample Copy of the Report @
https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6

Global Clopidogrel Market: Trends and Prospects

The primary factor for the increased demand for clopidogrel is the mounting population across the world who are suffering from cardiovascular diseases and related problems. Additionally, the changing lifestyle and increase in number of patients related with cardiovascular diseases among the emerging economies in the Asia Pacific region are also expected to be the major consumers for clopidogrel in the next six years. Moreover, the patent expiry of clopidogrel drug is anticipated to open floodgates for various pharmaceutical companies to venture into production of clopidogrel drug.

According to the World Heart Federation, nearly 15 million people suffer from heart attack or related problems globally. Out of these, roughly six million of these patients die while another five million are disabled permanently. This vast patient base is the primary factor that will sustain the demand during the forecast period.

Request TOC of the Report @
https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6

Global Clopidogrel Market: Geographical Outlook

Currently, North America and Europe contribute to the maximum demand for clopidogrel, owing to factors such as robust healthcare infrastructure and high affordability of the residents in this region. However, several countries in the region of Asia Pacific, such as China, India, and Japan are aggressively working towards improving their healthcare sector with the help of favorable policies by the localized governments and increasing disposable income among the urban population. Asia Pacific is home for nearly half of the world’s population, which makes for a high quantity of patient base. Additionally, these regions also have skilled labor at low cost which is encouraging players in the market to invest actively and tap the unmet demand.

Some of the key players in the global clopidogrel market are Pfizer, Dr Reddy’s, Apotex Corp, Roxane Laboratories, Aurobindo Pharma, Torrent Pharmaceuticals and Sun Pharma.

About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clopidogrel Market Competitive Analysis by 2025 : Pfizer, Dr Reddy’s, Apotex Corp, Roxane Laboratories, Aurobindo Pharma here

News-ID: 1690539 • Views: 270

More Releases from TMR Research

Cosmetic and Perfume Glass Packaging Market - Survey On Potential Players 2030 | …
Cosmetic and Perfume Glass Packaging Market: Overview The demand within the global cosmetic and perfume glass packaging market is slated to escalate in the times to follow. There is little contention about the importance of developing skin-friendly perfumes and cosmetics, prompting the manufacturers to ramp up their quality standards. However, quality of cosmetics and perfumes is not the only consideration that defines the growth dynamics of the entire industry. The growth
Biodegradable Cups Market - Consumer Outlook 2030 | Benders Paper Cup Company, W …
Global Biodegradable Cups Market: Overview The global biodegradable cups market is slated to expand at a stellar pace in the years to follow. It is worthwhile to note that the entire world is moving towards a greener and more sustainable future. This can be attributed to the efforts of environmentalists and young revolutionaries aiming to bring a change in the inclinations and mindsets of the masses. Therefore, the next decade is
Pre-press for Packaging Market - Worldwide Performance Report 2030 | Heidelberge …
Pre-press for Packaging Market: Overview The pre-press for packaging matter is anticipated to display notable growth over the forecast period from 2020 – 2030. The remarkable evolution of the printing sector is a key factor fuelling the pre-press for packaging market. Integration of computer-driven processes for printing and packaging solutions is creating opportunities in the pre-press for packaging market. Key parameters based on which the pre-press for packaging market is divided are
Artichokes Market Key Players, Latest Trends, Future Strategies And Growth Forec …
Global Artichokes Market: Overview Several botanists have studied the properties of edible plants over the years. This has led them to discover the health benefits of these plants, quite apparently for animals, and selectively for humans. Artichoke has also gained popularity due to increased spending on botanical and medical research. It is expected that the global artichokes market would expand at a sturdy pace in the years to follow. Research studies

All 5 Releases


More Releases for Clopidogrel

Global Clopidogrel Market Insights, Forecast
Clopidogrel, sold as the brandname Plavix among others, is an antiplatelet medication that is used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth. Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians
Clopidogrel Market - Top leading manufacturers 2025 | Pfizer, Dr Reddy’s
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market blustery by 2025
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market - Future demand Foreseen by 2025
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market - Geographical Outlook and Forecast 2017 - 2025
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market - Growth Prospects In Upcoming Years upto 2025
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are